Case Report: Prolonged response to cabozantinib and pembrolizumab in treatment-refractory metastatic pancreatic ductal adenocarcinoma

This article has no abstract
Epistemonikos ID: 56e87ff4458da6cd05c4785469bfa9bfee545821
First added on: Feb 21, 2026